• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者18岁前死亡的风险因素。

Risk factors for mortality before age 18 years in cystic fibrosis.

作者信息

McColley Susanna A, Schechter Michael S, Morgan Wayne J, Pasta David J, Craib Marcia L, Konstan Michael W

机构信息

Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia.

出版信息

Pediatr Pulmonol. 2017 Jul;52(7):909-915. doi: 10.1002/ppul.23715. Epub 2017 Apr 24.

DOI:10.1002/ppul.23715
PMID:28436621
Abstract

BACKGROUND

Understanding early-life risk factors for childhood death in cystic fibrosis (CF) is important for clinical care, including the identification of effective interventions.

METHODS

Data from the Epidemiologic Study of Cystic Fibrosis (ESCF) collected 1994-2005 were linked with the Cystic Fibrosis Foundation Patient Registry (CFFPR) demographic and mortality data from 2013. Inclusion criteria were ≥1 visit annually at age 3-5 years and ≥1 FEV measurement at age 6-8 years. Demographic data, nutritional parameters, pulmonary signs and symptoms, microbiology, and FEV were evaluated as risk factors for death before age 18 years. Multivariable Cox proportional hazards regression was used to model the simultaneous effects of risk factors associated with death before age 18 years.

RESULTS

Among 5365 patients enrolled in ESCF who met inclusion criteria, 3880 (72%) were linked to the CFFPR. Among these, 191 (5.7%) died before age 18 years; median age at death was 13.4 ± 3.1 years. Multivariable regression showed clubbing, crackles, female sex, unknown CFTR genotype, minority race or ethnicity, Medicaid insurance (a proxy of low socioeconomic status), Pseudomonas aeruginosa on 2 or more cultures, and weight-for-age <50th percentile were significant risk factors for death regardless of inclusion of FEV at age 6-8 years in the model.

CONCLUSION

We identified multiple risk factors for childhood death of patients with CF, all of which remained important after incorporating FEV at age 6-8 years. Among the factors identified were the presence of clubbing or crackles at age 3-5 years, signs which are not routinely collected in registries.

摘要

背景

了解囊性纤维化(CF)患儿死亡的早期风险因素对临床护理很重要,包括确定有效的干预措施。

方法

1994年至2005年收集的囊性纤维化流行病学研究(ESCF)数据与2013年囊性纤维化基金会患者登记处(CFFPR)的人口统计学和死亡率数据相关联。纳入标准为3至5岁时每年至少就诊1次,6至8岁时至少进行1次FEV测量。人口统计学数据、营养参数、肺部体征和症状、微生物学以及FEV被评估为18岁前死亡的风险因素。多变量Cox比例风险回归用于模拟与18岁前死亡相关的风险因素的同时作用。

结果

在符合纳入标准的5365名ESCF登记患者中,3880名(72%)与CFFPR相关联。其中,191名(5.7%)在18岁前死亡;死亡中位年龄为13.4±3.1岁。多变量回归显示,杵状指、啰音、女性、CFTR基因型未知、少数族裔、医疗补助保险(社会经济地位低的指标)、2次或更多次培养中出现铜绿假单胞菌以及年龄别体重<第50百分位数是死亡的重要风险因素,无论模型中是否纳入6至8岁时的FEV。

结论

我们确定了CF患儿死亡的多个风险因素,在纳入6至8岁时的FEV后,所有这些因素仍然很重要。所确定的因素包括3至5岁时出现杵状指或啰音,这些体征在登记处通常不常规收集。

相似文献

1
Risk factors for mortality before age 18 years in cystic fibrosis.囊性纤维化患者18岁前死亡的风险因素。
Pediatr Pulmonol. 2017 Jul;52(7):909-915. doi: 10.1002/ppul.23715. Epub 2017 Apr 24.
2
Case-mix adjustment for evaluation of mortality in cystic fibrosis.用于评估囊性纤维化死亡率的病例组合调整
Pediatr Pulmonol. 2002 Feb;33(2):99-105. doi: 10.1002/ppul.10042.
3
Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.在囊性纤维化患者中,幼儿期肺功能比早期铜绿假单胞菌感染更能预测青少年期肺功能。
PLoS One. 2017 May 15;12(5):e0177215. doi: 10.1371/journal.pone.0177215. eCollection 2017.
4
[Italian Cystic Fibrosis Register - Report 2010].[意大利囊性纤维化登记处——2010年报告]
Epidemiol Prev. 2016 Mar-Apr;40(2 Suppl 2):1-47. doi: 10.19191/EP16.2S2.P001.074.
5
Pulmonary outcome prediction (POP) tools for cystic fibrosis patients.囊性纤维化患者的肺部预后预测(POP)工具。
Pediatr Pulmonol. 2010 Dec;45(12):1156-66. doi: 10.1002/ppul.21311. Epub 2010 Aug 17.
6
CFTR genotype as a predictor of prognosis in cystic fibrosis.囊性纤维化跨膜传导调节因子(CFTR)基因型作为囊性纤维化预后的预测指标
Chest. 2006 Nov;130(5):1441-7. doi: 10.1378/chest.130.5.1441.
7
The determinants of survival among adults with cystic fibrosis-a cohort study.囊性纤维化成人生存的决定因素:一项队列研究。
J Physiol Anthropol. 2021 Nov 8;40(1):19. doi: 10.1186/s40101-021-00269-7.
8
[Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].[意大利囊性纤维化注册机构(ICFR)。2015 - 2016年报告]
Epidemiol Prev. 2019 Jul-Aug;43(4S1):1-36. doi: 10.19191/EP19.4.S1.067.
9
Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.使用基线特征对囊性纤维化患者进行最新和预计的生存估计:一项使用英国患者登记数据的纵向研究。
J Cyst Fibros. 2018 Mar;17(2):218-227. doi: 10.1016/j.jcf.2017.11.019. Epub 2018 Jan 6.
10
CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.囊性纤维化病携带成年患者的 CFTR 基因型与临床结局
Gene. 2014 May 1;540(2):183-90. doi: 10.1016/j.gene.2014.02.040. Epub 2014 Feb 26.

引用本文的文献

1
Building Lay Society Knowledge and Education for Health Technology Assessment and Policy Engagement: Case of CFTR Modulator Access in Brazil.构建面向卫生技术评估与政策参与的公众社会知识与教育:以巴西CFTR调节剂的可及性为例
Healthcare (Basel). 2025 Aug 14;13(16):1996. doi: 10.3390/healthcare13161996.
2
State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists.最新综述:囊性纤维化患者护理的变革性变化:对传染病专家的启示
Clin Infect Dis. 2025 Jun 4;80(5):e65-e77. doi: 10.1093/cid/ciaf009.
3
Factors associated with cystic fibrosis mortality before the age of 30: retrospective analysis of a cohort in southern Brazil.
与 30 岁前囊性纤维化死亡相关的因素:巴西南部队列的回顾性分析。
Braz J Med Biol Res. 2024 Aug 23;57:e13476. doi: 10.1590/1414-431X2024e13476. eCollection 2024.
4
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.临床微生物学实验室实用指南:更新的囊性纤维化患者呼吸道样本处理指南。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0021521. doi: 10.1128/cmr.00215-21. Epub 2024 Aug 19.
5
Cystic fibrosis.囊性纤维化。
Nat Rev Dis Primers. 2024 Aug 8;10(1):53. doi: 10.1038/s41572-024-00538-6.
6
Genome-wide association study of susceptibility to infection in cystic fibrosis.全基因组关联研究易感性感染在囊性纤维化。
Eur Respir J. 2024 Nov 7;64(5). doi: 10.1183/13993003.00062-2024. Print 2024 Nov.
7
Exhaled Breath Analysis Detects the Clearance of from the Airways of Children with Cystic Fibrosis.呼气分析可检测囊性纤维化患儿气道中**(此处原文缺失具体物质)**的清除情况。
Biomedicines. 2024 Feb 14;12(2):431. doi: 10.3390/biomedicines12020431.
8
Food insecurity screening and local food access: Contributions to nutritional outcomes among children and adults with cystic fibrosis in the United States.食物不安全筛查与当地食物获取:对美国囊性纤维化患者儿童和成人营养结局的影响。
J Cyst Fibros. 2024 May;23(3):524-531. doi: 10.1016/j.jcf.2023.08.006. Epub 2023 Sep 4.
9
Early life growth trajectories in cystic fibrosis are associated with lung function at age six.囊性纤维化患儿早期生长轨迹与 6 岁时的肺功能相关。
J Cyst Fibros. 2023 May;22(3):395-401. doi: 10.1016/j.jcf.2023.02.008. Epub 2023 Feb 28.
10
Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases.噬菌体:对抗慢性气道疾病中性粒细胞炎症的新型治疗手段。
Front Med (Lausanne). 2022 Dec 14;9:1069929. doi: 10.3389/fmed.2022.1069929. eCollection 2022.